TABLE 3.
Peptide | α3β2 |
α6/α3β2β3 |
||||
---|---|---|---|---|---|---|
IC50 | 95% C.I. | IC50 ratio relative to PeIAa | IC50 | 95% C.I. | IC50 ratio relative to PeIAa | |
PeIA | 19.2 nm | 17.2–21.5 | 0 | 17.2 nm | 15.1–19.5 | 0 |
PeIA(S9H,V10A,N11R) | 34.0 nm | 31.3–37.4 | 0.2 | 1.48 nm | 1.18–1.16 | −1.1 |
PeIA(A7V,S9H,V10A,N11R) | 10.1 μm | 6.90–17.1 | 2.7 | 2.53 nm | 2.14–2.98 | −0.8 |
PeIA(S9H,V10A,N11R,E14A) | 106 nm | 79.2–142 | 0.7 | 4.91 nm | 4.28–5.61 | −0.5 |
PeIA(A7V,S9H,V10A,N11R,E14A) | 30.9 μm | 22.8–42.1 | 3.2 | 2.16 nm | 1.98–2.35 | −0.9 |
a Indicates the log change in the ratio of IC50 values relative to PeIA. Negative values indicate an increase in potency, whereas positive values indicate a decrease in potency.